NVO   $36.75  4.14% Market Closed After Close 36.63 -0.33%

Novo Nordisk A/S

EMA (20): 2026-02-03 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2026-02-03 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2026-02-03 the price crossed down the moving average line and demonstrates a downside trend.

RSI: RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: exit from the oversold zone.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: main and signal line crossing.

Trend Type flat and down
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -28.16%
EMA (20) date of signal Feb. 3, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -28.16%
EMA (50) date of signal Feb. 3, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -28.16%
EMA (100) date of signal Feb. 3, 2026, 3 a.m.
RSI Signals bullish reversal
RSI (14) Yield 0.0
RSI (14) date of signal March 31, 2026, 3 a.m.
MACD Signals bullish reversal
MACD Yield -6.34%
MACD date of signal March 6, 2026, 3 a.m.
Stochastic Signals bullish reversal
Stochastic Yield 0.0
Stochastic date of signal March 31, 2026, 3 a.m.
Updated March 31, 2026, 11:01 p.m.